PeptadexPEPTADEX
Back to Library

BPC-157

Also known as: Body Protection Compound 157, Pentadecapeptide BPC 157

Healing & RecoveryPRECLINICAL

Clinical Status

Preclinical — FDA Category 2 (restricted from compounding, Sep 2023). Only 3 small human pilot studies exist.

Mechanism of Action

Modulates the nitric oxide system, promotes angiogenesis (new blood vessel formation), and upregulates growth hormone receptors. Interacts with the dopaminergic system and accelerates tendon-to-bone healing by promoting collagen synthesis.

Dosing Defaults

Dose

250-500 mcg

Frequency

2x daily

Administration

Subcutaneous injection near injury site, or systemic

Timing

Morning and evening

Food

with or without

Duration

4-12 weeks

Dose range: 200-1,000 mcg per day total

Split dosing maintains stable levels. Can be timed around activity for injury healing.

Side Effects

  • •Nausea
  • •Dizziness
  • •Injection site reactions
  • •Fatigue
  • •Headache
  • •May trigger histamine release

Contraindications & Warnings

  • ⚠Active cancer
  • •Not medical advice
  • •FDA Category 2 — restricted from compounding

Compare

Compare BPC-157 with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your BPC-157 dose.

Open Calculator

Ad

Related Healing & Recovery Peptides

TB-500

PRECLINICAL
Healing & Recovery

Synthetic fragment of Thymosin Beta-4 used for tissue repair and recovery.

Pentadecapeptide

PRECLINICAL
Healing & Recovery

Research peptide studied for wound healing and tissue regeneration.

Thymosin Beta-4

PHASE 2
Healing & Recovery

Full-length thymosin protein for wound healing and cardiac tissue repair.

GHK

PHASE 2
Healing & Recovery

Naturally occurring tripeptide for tissue remodeling without the copper component.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.